AU2003287040A1 - Screening combinatorial bead libraries for cancer ligands - Google Patents
Screening combinatorial bead libraries for cancer ligandsInfo
- Publication number
- AU2003287040A1 AU2003287040A1 AU2003287040A AU2003287040A AU2003287040A1 AU 2003287040 A1 AU2003287040 A1 AU 2003287040A1 AU 2003287040 A AU2003287040 A AU 2003287040A AU 2003287040 A AU2003287040 A AU 2003287040A AU 2003287040 A1 AU2003287040 A1 AU 2003287040A1
- Authority
- AU
- Australia
- Prior art keywords
- screening combinatorial
- bead libraries
- combinatorial bead
- cancer ligands
- ligands
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
- C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
- G01N33/5017—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2003/032031 WO2005045430A1 (en) | 2003-10-08 | 2003-10-08 | Screening combinatorial bead libraries for cancer ligands |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003287040A1 true AU2003287040A1 (en) | 2005-05-26 |
Family
ID=34572281
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003287040A Abandoned AU2003287040A1 (en) | 2003-10-08 | 2003-10-08 | Screening combinatorial bead libraries for cancer ligands |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003287040A1 (en) |
WO (1) | WO2005045430A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1759212B1 (en) | 2004-05-25 | 2008-12-17 | 2Curex | Identification of compounds modifying a cellular response |
WO2007009457A2 (en) * | 2005-07-18 | 2007-01-25 | 2Curex Aps | Identification of protein ligands modifying a cellular response |
EP2066689A4 (en) | 2006-09-07 | 2010-04-28 | Univ South Florida | Hyd1 peptides as anti-cancer agents |
KR101793082B1 (en) * | 2009-09-24 | 2017-11-02 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | Bladder cancer specific ligand peptides |
WO2011115688A2 (en) | 2010-03-19 | 2011-09-22 | H. Lee Moffitt Cancer Center & Research Institute | Integrin interaction inhibitors for the treatment of cancer |
MX2013011000A (en) | 2011-03-24 | 2014-03-27 | Opko Pharmaceuticals Llc | Biomarker discovery in complex biological fluid using bead or particle based libraries and diagnostic kits and therapeutics. |
WO2015048477A1 (en) | 2013-09-27 | 2015-04-02 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Cyclic peptide conjugates and methods of use |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6670142B2 (en) * | 2001-10-26 | 2003-12-30 | The Regents Of The University Of California | Method for screening combinatorial bead library, capturing cells from body fluids, and ligands for cancer cells |
-
2003
- 2003-10-08 WO PCT/US2003/032031 patent/WO2005045430A1/en active Application Filing
- 2003-10-08 AU AU2003287040A patent/AU2003287040A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2005045430A1 (en) | 2005-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002249116A1 (en) | Gene library for screening methods | |
AU2002315157A1 (en) | Methods of screening for ligands of target molecules | |
AU2003218415A1 (en) | Combinatorial synthesis | |
WO2004070351A3 (en) | Protein fragment complementation assays for high-throughput and high-content screening | |
GB0307214D0 (en) | Compound libraries | |
AU2003282634A1 (en) | Combinatorial synthesis system | |
EP1572978A3 (en) | Bead bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries | |
AU2003214626A1 (en) | Breast cancer screening | |
EP1513879A4 (en) | Synthetic antibody phage libraries | |
IL173471A0 (en) | Multiple high-resolution serum proteomic features for ovarian cancer detection | |
EP1654526A4 (en) | Biomarker panel for colorectal cancer | |
AU2003274053A1 (en) | Aryloxyalkylamine derivates as h3 receptor ligands | |
AU2003235749A1 (en) | Biomarkers for detecting ovarian cancer | |
AU2003213960A1 (en) | Methods for detecting ovarian cancer | |
AU2003287040A1 (en) | Screening combinatorial bead libraries for cancer ligands | |
AU2003247435A1 (en) | Combinatorial chemical library ii | |
AU2003272964A1 (en) | Remedy for hormone-dependent cancer | |
EP1606399A4 (en) | Method of screening for target ligands | |
GB0313762D0 (en) | Compound libraries | |
HK1105451A1 (en) | Methods for antibody library screening | |
AU2002258787A1 (en) | Screening methods for identifying ligands | |
AU2003239666A1 (en) | Antibody screening libraries | |
GB0320983D0 (en) | Compound libraries | |
AU2003285503A1 (en) | Screening method | |
AU2002317009A1 (en) | Screening method for identifying cancer therapy-relevant compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |